FILTER
FILTERED INTERVIEW RESULTS
Michael Gladstone
PRINCIPAL, ATLAS VENTURE
Atlas Venture is an early-stage venture capital firm that invests in life sciences startup companies in the US.
Akshay Charegaonkar
DIRECTOR, ANCHROM ENTERPRISES
Anchrom Enterprises offers high-end analytical solutions together with technical expertise, acting as the exclusive distributors of Camag HPTLC.
Bhagyesh Shah
MANAGING DIRECTOR, UNISON PHARMACEUTICALS
Unison Pharmaceuticals Private Limited was established in 1981, with a vision of providing quality affordable medicines across India and is now ready to go global.
David DeJean
SENIOR VICE PRESIDENT, SYSTECH INTERNATIONAL
Systech International is a technology leader in supply chain safety and brand protection.
Krishna Kanumuri
CEO, SAI LIFE SCIENCES
Sai Life Sciences delivers advanced discovery, contract development and manufacturing solutions through a broad suite of capabilities across the molecular lifecycle.
Pelin İșçener
MARKETING AND SALES DIRECTOR, ECZACIBAȘI MONROL NÜKLEER ÜRÜNLER
Eczacıbaşı Monrol specializes in producing agents for PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scans, which are critical for detecting cancer, cardiological diseases and brain disorders, among other serious diseases.
Cem Erdem
CO-FOUNDER AND CEO, FLORABIO TEKNOLOJI
Florabio is a life science company with proprietary technology, know-how and experience in research and development of therapeutic proteins.
Muzaffer Bal
GENERAL MANAGER, ALI RAIF
Ali Raif is one of the oldest Turkish Pharmaceutical companies, and has developed from manufacturing and marketing under license to producing generics and other drugs.
Robert Foster
CEO, HEPION PHARMACEUTICALS
Hepion Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease.
Daniel J O’Connor
PRESIDENT & CEO, ONCOSEC MEDICAL INCORPORATED
OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using its plasmid DNA delivery platform.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Peru Mining 2025 Pre-Release II
Featuring insights from nearly 50 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting the country's window of opportunity with the energy transition and copper's critical role.
Featuring insights from nearly 50 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting the country's window of opportunity with the energy transition and copper's critical role.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
